CRISPR/Cas9 technology generated a T to C change at position 1613 (c.T1613C) resulting in an isoleucine to threonine substitution at amino acid 536 (p.I538T). This corresponds to the human c.T1607C (p.I536T) variant that was identified in two patients with sudden death without apparent dilated cardiomyopathy. (J:335127)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count